uniQure N.V. 0EE0.L
0EE0.L
uniQure N.V. 0LB2.L
Supernus Pharmaceuticals, Inc. 0HF9.L
Amicus Therapeutics, Inc. 0JBU.L
Intellia Therapeutics, Inc. 0HB0.L
Agios Pharmaceuticals, Inc. 0L35.L
Sarepta Therapeutics, Inc. 0IDA.L
Dynavax Technologies Corporation 0Y5E.L
Perrigo Company plc 0IGA.L
Emergent BioSolutions Inc. 0JDK.L
Iovance Biotherapeutics, Inc.
uniQure N.V. 0LB2.L
Supernus Pharmaceuticals, Inc. 0HF9.L
Amicus Therapeutics, Inc. 0JBU.L
Intellia Therapeutics, Inc. 0HB0.L
Agios Pharmaceuticals, Inc. 0L35.L
Sarepta Therapeutics, Inc. 0IDA.L
Dynavax Technologies Corporation 0Y5E.L
Perrigo Company plc 0IGA.L
Emergent BioSolutions Inc. 0JDK.L
Iovance Biotherapeutics, Inc.
Performance
| Periode | 0EE0.L | 0LB2.L | 0HF9.L | 0JBU.L | 0HB0.L | 0L35.L | 0IDA.L | 0Y5E.L | 0IGA.L | 0JDK.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 341.40 % | 66.61 % | 18.44 % | 89.08 % | 48.25 % | -61.43 % | -2.80 % | -13.81 % | 77.26 % | -35.19 % |
| YTD | 245.98 % | 46.89 % | -7.86 % | 27.51 % | 31.46 % | -81.31 % | -20.12 % | -17.69 % | 0.22 % | -71.13 % |
| 1Y | 818.25 % | 55.00 % | -25.19 % | -5.63 % | -4.89 % | -81.92 % | -7.14 % | -15.50 % | 3.56 % | -79.03 % |
| 3Y | 232.98 % | 53.79 % | -17.66 % | -70.88 % | 52.80 % | -79.00 % | -9.72 % | -35.15 % | -52.58 % | -76.93 % |
| 5Y | 47.00 % | 143.83 % | -9.12 % | -83.97 % | 28.80 % | -69.57 % | -9.17 % | -35.15 % | -89.59 % | -90.47 % |
| 10Y | 224.39 % | 28.71 % | -9.12 % | -83.97 % | -45.49 % | -69.57 % | -9.17 % | -35.15 % | -80.38 % | -90.47 % |
| From the beginning | 224.39 % | 28.71 % | -9.12 % | -83.97 % | -45.49 % | -69.57 % | -9.17 % | -35.15 % | -80.38 % | -90.47 % |